← All trials
NCT05160987
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2022
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2024
- First posted
- Dec 16, 2021
- Last posted
- Dec 16, 2021
- Enrollment
- 440
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Southern Medical UniversityLead sponsor
- Guangzhou Medical UniversityCollaborator
- Guangzhou Medical UniversityCollaborator
- Shantou UniversityCollaborator
- Xiamen UniversityCollaborator
- Southern Medical UniversityReponsible party - principal investigator
- Southern Medical UniversityCollaborator
- Southern Medical UniversityOverall official - principal investigator
- Shenzhen UniversityCollaborator
- Shenzhen UniversityCollaborator
- Yunfu People's HospitalCollaborator
- Guangzhou UniversityCollaborator
- Huizhou Third People's HospitalCollaborator
- Southern Medical UniversityCollaborator
- The Second People's Hospital of FoshanCollaborator
- Shanwei People's HospitalCollaborator
- The Fourth People's Hospital of FoshanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.